AtkinsRealis Group Inc (ATRL)
Toronto Stock Exchange · Canada · prices in CAD · close of 27 Oct 2026
Key indicators
| Last close | CAD 86.63 |
|---|---|
| 52-week range | 79.16 – 106.82 |
| Return, 1 month / 3 months | +0.5% / −3.1% |
| Return, 1 year / 3 years | −12.2% / +131.4% |
| Trend | Below its 200-day average |
| RSI (14) | 51 |
| Volatility (1 year) | 34.8% |
| Worst drawdown (1 year) | -24.6% |
| Average daily value traded | 46.54M CAD |
| Dividend yield | 0.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
AtkinsRéalis Group is a professional services and engineering company based in Canada. It provides engineering, design, project management and construction support to clients in sectors such as infrastructure, power, nuclear energy and industry. Its engineers and consultants work on transport networks, buildings, water systems and energy facilities for governments and private companies in markets around the world, and it also offers nuclear technology and support services through its specialist divisions.
The shares are listed on the Toronto Stock Exchange in Canada under the code ATRL, and the price on this page is in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
AtkinsRealis Group Inc (ATRL) trades on the Toronto Stock Exchange in Canada. It last closed at CAD 86.63 on 27 October 2026.
Its price-based Market X-Ray is 52 out of 100 (a fair price profile), ranking 451 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 12.2% and over the last three months it fell 3.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 43 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -3.2% | ||
| From 52-week high | -18.2% | ||
| Momentum | 35 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -3.1% | ||
| 6-month return | -6.7% | ||
| 12-month return, skipping the last month | -12.6% | ||
| Stability (higher is calmer) | 60 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 34.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.6% | ||
| Liquidity | 91 · Strong | Trades actively. | |
| Average daily value traded | 46.54M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 35 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.1% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | +2.3% |
|---|---|
| 1 month | +0.5% |
| 3 months | −3.1% |
| 6 months | −6.7% |
| 1 year | −12.2% |
| 3 years | +131.4% |
| 5 years | +152.4% |
Signals
| 50-day / 200-day average | 86.31 / 89.51 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.44 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Aug 2026 | CAD 0.0200 |
| 28 May 2026 | CAD 0.0200 |
| 13 Mar 2026 | CAD 0.0200 |
| 27 Nov 2025 | CAD 0.0200 |
| 21 Aug 2025 | CAD 0.0200 |
| 29 May 2025 | CAD 0.0200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.